GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF

(2014) Nobuto Yamamoto et al.   Translational Oncology

Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling

(2012) Stefania Pacini et al.   JOURNAL OF NEPHROLOGY

Mere anecdote: evidence and stories in medicine

(2011) Robin Nunn   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay

(2010) Stefania Pacini et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice

(2010) Koichi Nonaka et al.   JOURNAL OF SURGICAL RESEARCH

Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells

(2010) Kalvin J. Gregory et al.   PLoS One

Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity

(2009) Marilena Greco et al.   CANCER LETTERS

Glycosylation status of vitamin D binding protein in cancer patients

(2009) Douglas S. Rehder et al.   PROTEIN SCIENCE

Retracted: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF)

(2008) Nobuto Yamamoto et al.   JOURNAL OF MEDICAL VIROLOGY